Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda patent portfolio — 90 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
19
Drugs
283
Patents
90
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Takeda patents

90 pharmaceutical patents indexed for Takeda. 3 expire within 24 months.

Takeda has 90 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

90 patents

Patent portfolio

Page 1 of 2

  1. US 12336990

    Treatment of prostate cancer

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12295940

    Viral inhibitors, the synthesis thereof, and intermediates thereto

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12291556

    Parathyroid hormone variants

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12246064

    Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12213989

    Use of maribavir in treatment regimens

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12202832

    Heterocyclic compounds having a calcium-sensing receptor antagonistic activity

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12144809

    Treatment of prostate cancer

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12097198

    Treatment of prostate cancer

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11957684

    Treatment of heavy menstrual bleeding associated with uterine fibroids

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11884731

    Vedolizumab for the treatment of fistulizing Crohn's disease

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11793812

    Methods of treating endometriosis

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11684632

    Maribavir isomers, compositions, methods of making and methods of using

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11583526

    Treatment of prostate cancer

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11464869

    Non-adult human dosing of brentuximab vedotin

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11033551

    Methods of treating uterine fibroids

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10786501

    Treatment of prostate cancer

    Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10449191

    Treatment of prostate cancer

    Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10357460

    Particulate comprising a calcium-containing compound and a sugar alcohol

    Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10350170

    Solid preparation

    Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10258576

    Particulate comprising a calcium-containing compound and a sugar alcohol

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9999634

    Dissolution stability of calcium carbonate tablets

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9889125

    Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9801907

    Film-coated and/or granulated calcium-containing compounds and use therof in pharmaceutical compositions

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9617303

    Sustained-release composition and method for producing the same

    Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9447100

    Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9422327

    Process for preparing crystalline ciclesonide with defined particle size

    Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9387249

    Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone

    Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9320714

    Tablet

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9278096

    Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9255063

    Colchicine solid-state forms; methods of making; and methods of use thereof

    Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9241910

    Orally-disintegrating solid preparation

    Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9238029

    Multiple PPI dosage form

    Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9233103

    Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy

    Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9205044

    Aqueous pharmaceutical preparation comprising roflumilast

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9186411

    Pharmaceutical composition

    Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9169238

    Solid pharmaceutical composition

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9107912

    Methods for concomitant treatment of theophylline and febuxostat

    Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9101565

    Dissolution stability of calcium carbonate tablets

    Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9101660

    Solid preparation

    Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9066936

    Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent

    Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9011926

    Method for producing granules

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8921326

    Sustained-release composition and method for producing the same

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8906411

    Pre-compacted calcium-containing compositions

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8900638

    Solid preparation comprising alogliptin and metformin hydrochloride

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8871273

    Method for producing granules

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8846088

    Melt granulation of a composition containing a calcium-containing compound

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8846101

    Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8808735

    Fast wet-massing method for the preparation of calcium-containing compositions

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

90 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.